Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis

Experimental Cell Research

Volumn 266, Issue 1, 2001, Pages 31-43

  Spisni, Enzo ^a   Griffoni, Cristiana ^a   Santi, Spartaco ^b   Riccio, Massimo ^b   Marulli, Roberta ^a   Bartolini, Giovanna ^a   Toni, Mattia ^a   Ullrich, Volker ^c   Tomasi, Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Angiogenesis; Antisense oligonucleotides; Caveolae; Caveolin 1; Confocal microscopy; GST fusion protein; PGI2 synthase

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CAVEOLIN 1; FILIPIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PROSTACYCLIN SYNTHASE;

ANGIOGENESIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM VESICLE; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEMINAL VESICLE; SMOOTH MUSCLE FIBER;

EID: 0035872246     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5198     Document Type: Article

References (66)

1. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
2. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells
3. Pharmacology and endogenous roles of prostaglandin endoperoxides thromboxane A2 and prostacyclin
4. Biosynthesis of prostacyclin in rat liver endothelial cells and its control by prostaglandin E2
5. Molecular mechanisms of diverse actions of prostanoid receptors
6. Hypolipidemic drugs, polyunsatured fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
7. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension
8. Human prostacyclin synthase gene and hypertension: The Suita Study
9. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR δ
10. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells
11. Molecular cloning and characterization of bovine prostacyclin synthase
12. Molecular cloning of human prostacyclin synthase
13. Prostacyclin synthase active sites. Identification by molecular modeling-guided site-directed mutagenesis
14. 2 synthase antigen in smooth muscle cells
15. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells
16. Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells
17. Cellular aspects of transcapillary exchange
18. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules
19. Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells
20. Caveolae and caveolins
21. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
22. Caveolae: Uniform structures with multiple functions in signaling, cell growth, and cancer
23. Prostacyclin synthase is localized in rat, bovine and human neuronal brain cells
24. Multiple fluorescence and reflectance simultaneous detection by confocal microscopy of HaeIII digested DNA sequences
25. Endothelial nitric oxide synthase targeting to caveolae
26. VIP 21/caveolin, glycosphingolipid clusters and sorting of glycophosphatilinositol-anchored proteins in epithelial cells
27. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface
28. Cholesterol is required for surface transport of influenza virus hemagglutinin
29. Post-transcriptional regulation of thromboxane A2 synthase in U937 cells
30. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
31. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking
32. A role of caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
33. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
34. Vascular endothelial growth factor induces endothelial fenestrations in vitro
35. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
36. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity
37. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2
38. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
39. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
40. Subcellular localization of prostaglandin endoperoxide synthase-1 and -2 by immunoelectron microscopy
41. Caveolin internalization by heat shock or hyperosmotic shock
42. Tyrosine phosphorylation of caveolin-1 in the endothelium
43. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
44. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo
45. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
46. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, caveolin-1 in vascular endothelial cells
47. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite
48. Interleukin 1 beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation
49. NADH oxidoreductase is a major source of superoxide anion in in bovine coronary endothelium
50. Release of hydrogen peroxide in response to hypoxia-reoxygenation: Role of an NAD(P)H-oxidase like enzyme in endothelial cell plasma membrane
51. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1: The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro
52. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin
53. Identification of peptide and protein ligands for the caveolin-scaffolding domain: Implications for the interaction of caveolin with caveolae-associated proteins
54. Caveolae, caveolar enzymes and angiogenesis
55. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
56. Fatty acylation of proteins: New insights into membrane targeting of myrstoylated and palmitoylated proteins
57. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
58. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
59. Involvement of prostanoids in angiogenesis
60. Orally active prostacyclin analog in primary pulmonary hypertension
61. Pulmonary hypertension - Beyond vasodilator therapy
62. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension
63. Prostacyclin synthase gene transfer accelerates reendothelialisation and inhibits neointimal formation in rat carotid arteries after balloon injury
64. Knock down of caveolin-1 by antisense oligonucleotides impairs anglogenesis in vitro and in vivo
65. Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells
66. Caveolins, liquid-ordered domains, and signal transduction